INTRODUCTION {#sec1-1}
============

Herpes simplex viruses (HSVs) exist as two major serotypes, HSV-1 and HSV-2 both of which can cause genital herpes.\[[@ref1]\] The type of HSV infection affects prognosis and subsequent counseling; thus, type-specific testing to distinguish HSV-1 from HSV-2 is recommended.\[[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7]\] The aim of this study was to compare the laboratory tests which were able to simultaneously detect and type HSV directly from the genital ulcer specimens. In this study, we compared glycoprotein-G (gG) gene-based conventional polymerase chain reaction (PCR) with commercially available monoclonal antibody-based direct fluorescent antibody (DFA) test in a tertiary care hospital in New Delhi, India.

MATERIALS AND METHODS {#sec1-2}
=====================

With the institutional ethics committee approval, a study was conducted from July 2012 to January 2013 in which 44 adult male and female patients who were clinically suspected to have genital herpes were included. Patients who have received treatment for genital herpes in preceding 4 weeks were excluded from the study. The recruited patients were grouped on the basis of clinical presentation into five different categories -- primary genital herpes and recurrent genital herpes on the basis of the time of presentation; and genital vesicles, ulcers, and crusted erosions on the basis of the type of genital lesion at the time of presentation. We did not include any healthy or other nonherpes ulcer control.

Clinical specimens {#sec2-1}
------------------

Genital ulcer swab specimens were separately collected for PCR and DFA with sterile dacron swabs which were immediately placed in viral transport medium (HiMedia, India) and transported to the laboratory in an ice box immediately and placed in a deep freezer at −70°C till further processing.

Preparation of genomic DNA {#sec2-2}
--------------------------

DNA extraction was performed using QiaAmp DNA mini kit (Qiagen, USA) blood or body fluids spin protocol and the extract was stored at −20°C in aliquots till used for amplification. HSV primers: Type-specific gG gene-based HSV primers were used as follows: HSV-1 (forward primer) 5\'-CCCCCATGCCAAGTATTGGA-3\', HSV-2 (forward primer) 5\'-AGCTCCCGCTAAGGACATG-3\', HSV-1 and 2 (reverse primer) 5\'-AGACATACGTAACGCACGCT-3\'.

Polymerase chain reaction condition {#sec2-3}
-----------------------------------

PCR reaction contained 25 μl of PCR master mix, 2 μl of forward and reverse HSV primers each (10 pm), 8 μl of DNA extract, and 7.5 μl of deionized nuclease free water to obtain a final volume of 50 μl. PCR amplification was carried out in GeneAmp PCR -- 9700 thermocycler (Applied Biosystems, USA). The thermal profile was initial denaturation at 94°C for 3 min, followed by denaturation at 94°C for 45 s, annealing and extension at 72°C for 1 min (35 cycles), and final extension at 72°C for 5 min. PCR products were electrophoresed and visualized on 2% agarose. Amplicons were identified and differentiated as follows: HSV-1 gG PCR amplicon size -- 487 bp and HSV-2 gG PCR amplicon size -- 214 bp.

Direct fluorescent antibody test {#sec2-4}
--------------------------------

It was performed using "Pathfinder HSV 1 and 2" (Bio-Rad Laboratories, USA) along with positive and negative control slides. Interpretation of the test was performed as follows: (1) Positive: Specimen containing at least one epithelial cell displaying specific apple green fluorescence in HSV-1 and/or HSV-2 well (s) and compared with positive control slides. (2) Negative: Specimen containing minimum of 10 epithelial cells in both HSV-1 and HSV-2 wells stained red due to the counterstain. The results of PCR and DFA were compared in all the above-mentioned categories based on clinical presentation of the disease.

Statistical analysis {#sec2-5}
--------------------

The significance of difference between the two tests was calculated by McNemar test using Statistical Package for Social Science software (SPSS version 20.0, IBM Corp., Armonk, NY) (*P* \< 0.05 was considered statistically significant). The measure of agreement between the two laboratory tests was determined by Kappa index, where value of 1.0 indicates complete agreement.

RESULTS {#sec1-3}
=======

A total of 44 patients were recruited during the study of which 21 (48%) presented with primary genital herpes and 23 (52%) with recurrent genital herpes. Of the total patients, 31 (70%) presented with ulcerative genital lesions, 4 (9%) with vesicular lesions, and the remaining 9 (21%) with crusted erosions. PCR was positive in a total of 36 (82%) specimens of which 18 (85.71%) cases were of primary and 18 (78.26%) cases of recurrent genital herpes (*P* = 0.701). PCR was positive in all the cases of vesicular lesions, 81% cases of ulcerative lesions, and 78% cases with crusted erosions. DFA was also positive in all the cases of vesicular lesions, but in 71% cases with ulcerative lesions and in 44% cases with crusted erosions (*P* \> 0.05) \[[Table 1](#T1){ref-type="table"}\].

###### 

Results of direct fluorescent antibody and polymerase chain reaction among cases with genital herpes (*n*=44)
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When we compared our PCR results with DFA test, we found that there was a significant difference in results obtained by these tests in recurrent genital herpes cases (*P* = 0.031) but not in primary genital herpes (*P* = 1). The strength of agreement between the results of PCR and DFA was found to be better in primary genital herpes (κ =1) than recurrent cases (κ =0.6). There was 100% agreement in DFA and PCR results in vesicular lesions (κ =1). Similarly, the strength of agreement between the results was better in vesicular than ulcerative than crusted erosions \[Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}\].

###### 

Comparison between direct fluorescent antibody and polymerase chain reaction in primary and recurrent genital herpes (*n*=44)
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###### 

Comparison between direct fluorescent antibody and polymerase chain reaction in different types of genital lesions (*n*=44)
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DISCUSSION {#sec1-4}
==========

In our study, PCR for HSV was positive in 82% (36/44) cases. Another study also showed that in 87.8% cases, HSV was demonstrated by real-time PCR.\[[@ref8]\] However, the positivity rate depends on many variables including clinical diagnosis, clinical presentation of the disease, collection of the specimens, and transport to name a few. We found that there was no significant difference in the positive cases detected by PCR in either primary or recurrent genital herpes cases (*P* = 0.701). This finding is similar to the observation by Ramaswami *et al*.\[[@ref9]\] We found that there was a significant difference in detection of positive cases by DFA and PCR in recurrent genital herpes (*P* = 0.031) but not in primary genital herpes (*P* = 1). There was 100% concordance in DFA and PCR results in vesicular lesions. We observed 100% agreement between HSV types detected by DFA and PCR. PCR was found to be better in diagnosis of the recurrent genital herpes patients and in healing lesions. Our findings are similar to the observation by Fang *et al*., who also used a similar gG gene-based PCR assay.\[[@ref10]\] We also observed that although DFA test was easy to perform and required \<1 h; it is costly and difficult to interpret. It also requires a fluorescent microscope which may not be available everywhere. However, PCR takes longer time and a little cumbersome to perform is easy to interpret and cheaper as compared to DFA test.

CONCLUSION {#sec1-5}
==========

PCR was found to be better in the detection of HSV in recurrent genital herpes patients; however, in primary genital herpes cases, both DFA and PCR are comparable to each other. Similarly, both these modalities are equally good in diagnosis of genital herpes when it presents clinically with vesicular lesions, but PCR is a better option when genital herpes clinically presents with ulcerative or crusted lesions. Moreover, PCR is a cheaper alternative as compared to DFA.

Limitations {#sec2-6}
-----------

We neither performed HSV culture nor have the clinical outcome of the patients to be considered as gold standard for comparison. Inclusion of either of it would have enabled us to calculate sensitivity and specificity of both the tests for assessing the routine applicability of these tests.
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